Journey Medical (DERM) Revenue & Revenue Breakdown
Journey Medical Revenue Highlights
Latest Revenue (Y)
$79.18M
Latest Revenue (Q)
$14.86M
Main Segment (Y)
Qbrexza
Journey Medical Revenue by Period
Journey Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $79.18M | 7.48% |
| 2022-12-31 | $73.67M | 16.69% |
| 2021-12-31 | $63.13M | 41.78% |
| 2020-12-31 | $44.53M | 27.52% |
| 2019-12-31 | $34.92M | -17.52% |
| 2018-12-31 | $42.34M | 832.37% |
| 2017-12-31 | $4.54M | -79.89% |
| 2016-12-31 | $22.59M | 209.38% |
| 2015-12-31 | $7.30M | - |
| 2014-12-31 | $7.30M | - |
Journey Medical generated $79.18M in revenue during NA 2023, up 7.48% compared to the previous quarter, and up 187.02% compared to the same period a year ago.
Journey Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $14.86M | 14.01% |
| 2024-03-31 | $13.03M | -14.60% |
| 2023-12-31 | $15.26M | -55.83% |
| 2023-09-30 | $34.54M | 101.14% |
| 2023-06-30 | $17.17M | 40.60% |
| 2023-03-31 | $12.21M | -23.51% |
| 2022-12-31 | $15.97M | -0.93% |
| 2022-09-30 | $16.12M | -11.89% |
| 2022-06-30 | $18.29M | -21.48% |
| 2022-03-31 | $23.30M | 32.99% |
| 2021-12-31 | $17.52M | -10.67% |
| 2021-09-30 | $19.61M | 28.27% |
| 2021-06-30 | $15.29M | 42.63% |
| 2021-03-31 | $10.72M | -21.89% |
| 2020-12-31 | $13.72M | 45.26% |
| 2020-09-30 | $9.45M | 0.34% |
| 2020-06-30 | $9.41M | -11.85% |
| 2020-03-31 | $10.68M | -7.39% |
| 2019-09-30 | $11.53M | -82.69% |
| 2019-06-30 | $66.64M | 2617.99% |
| 2019-03-31 | $2.45M | 9.32% |
| 2018-12-31 | $2.24M | 212.83% |
| 2018-09-30 | $717.00K | -98.17% |
| 2018-06-30 | $39.08M | 12970.23% |
| 2018-03-31 | $299.00K | -77.74% |
| 2017-12-31 | $1.34M | 25.98% |
| 2017-09-30 | $1.07M | - |
| 2017-06-30 | $1.07M | - |
| 2017-03-31 | $1.07M | -95.26% |
| 2016-12-31 | $22.47M | 18778.99% |
| 2016-09-30 | $119.00K | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $7.30M | - |
| 2015-09-30 | $7.30M | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | -100.00% |
| 2014-12-31 | $7.30M | - |
Journey Medical generated $14.86M in revenue during Q2 2024, up 14.01% compared to the previous quarter, and up 121.63% compared to the same period a year ago.
Journey Medical Revenue Breakdown
Journey Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Exelderm | $2.40M | $3.46M | $5.36M |
| Accutane | $20.17M | $18.37M | $10.05M |
| Amzeeq | $6.20M | $7.24M | - |
| Zilxi | $1.96M | $2.27M | - |
| Ximino | $287.00K | $4.96M | $8.25M |
| Targadox | $3.20M | $7.97M | $22.38M |
| Qbrexza | $25.41M | $26.71M | - |
| Other Branded Products | - | - | $37.00K |
| Qbrexa | - | - | $17.06M |
Journey Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Qbrexza (42.61%), Accutane (33.82%), Amzeeq (10.40%), Targadox (5.37%), Exelderm (4.02%), Zilxi (3.29%), and Ximino (0.48%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Amzeeq | $1.21M | $755.00K | $1.35M | $1.16M | $1.26M | $3.47M | - | - | - | - |
| Zilxi | $369.00K | $273.00K | $422.00K | $554.00K | $555.00K | $741.00K | - | - | - | - |
| Qbrexza | $6.84M | $5.02M | $17.33M | $8.08M | $6.96M | $6.26M | - | - | - | - |
| Accutane | $5.72M | $5.82M | $14.59M | $5.58M | $4.14M | $4.12M | $5.20M | $4.91M | $4.38M | $3.53M |
| Ximino | - | - | - | - | $1.18M | $1.77M | $1.03M | $967.00K | $1.97M | $2.86M |
| Exelderm | - | - | - | - | $445.00K | $1.00M | $1.31M | $704.00K | $1.04M | $1.37M |
| Targadox | - | - | - | - | $1.41M | $1.17M | $2.76M | $2.63M | $4.27M | $5.18M |
| Qbrexa | - | - | - | - | - | - | $6.11M | $7.38M | $5.85M | $6.64M |
| Other Branded Products | - | - | - | - | - | - | - | $1.00K | $2.00K | $29.00K |
Journey Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Qbrexza (48.38%), Accutane (40.48%), Amzeeq (8.53%), and Zilxi (2.61%).
Journey Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ORGO | Organogenesis | $433.14M | $130.23M |
| ACB | Aurora Cannabis | $233.29M | $64.42M |
| LFCR | Lifecore Biomedical | $128.26M | $35.70M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| DERM | Journey Medical | $79.18M | $14.86M |
| AQST | Aquestive Therapeutics | $50.58M | $20.10M |
| AVDL | Avadel Pharmaceuticals | $27.96M | $41.50M |
| JUPW | Safety Shot | $6.20M | $910.01K |
| EVOK | Evoke Pharma | $5.18M | $1.74M |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |
DERM Revenue FAQ
What is Journey Medical’s yearly revenue?
Journey Medical's yearly revenue for 2023 was $79.18M, representing an increase of 7.48% compared to 2022. The company's yearly revenue for 2022 was $73.67M, representing an increase of 16.69% compared to 2021. DERM's yearly revenue for 2021 was $63.13M, representing an increase of 41.78% compared to 2020.
What is Journey Medical’s quarterly revenue?
Journey Medical's quarterly revenue for Q2 2024 was $14.86M, a 14.01% increase from the previous quarter (Q1 2024), and a -13.49% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $13.03M, a -14.60% decrease from the previous quarter (Q4 2023), and a 6.69% increase year-over-year (Q1 2023). DERM's quarterly revenue for Q4 2023 was $15.26M, a -55.83% decrease from the previous quarter (Q3 2023), and a -4.44% decrease year-over-year (Q4 2022).
What is Journey Medical’s revenue growth rate?
Journey Medical's revenue growth rate for the last 3 years (2021-2023) was 25.42%, and for the last 5 years (2019-2023) was 126.74%.
What are Journey Medical’s revenue streams?
Journey Medical's revenue streams in c 23 are Exelderm, Accutane, Amzeeq, Zilxi, Ximino, Targadox, and Qbrexza. Exelderm generated $2.4M in revenue, accounting 4.02% of the company's total revenue, down -30.84% year-over-year. Accutane generated $20.17M in revenue, accounting 33.82% of the company's total revenue, up 9.77% year-over-year. Amzeeq generated $6.2M in revenue, accounting 10.40% of the company's total revenue, down -14.37% year-over-year. Zilxi generated $1.96M in revenue, accounting 3.29% of the company's total revenue, down -13.68% year-over-year. Ximino generated $287K in revenue, accounting 0.48% of the company's total revenue, down -94.21% year-over-year. Targadox generated $3.2M in revenue, accounting 5.37% of the company's total revenue, down -59.81% year-over-year. Qbrexza generated $25.41M in revenue, accounting 42.61% of the company's total revenue, down -4.88% year-over-year.
What is Journey Medical’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Journey Medical was Qbrexza. This segment made a revenue of $25.41M, representing 42.61% of the company's total revenue.